Posts By: Karen Jones

Study shows that drug slows brain shrinkage in multiple sclerosis

Source UAB News: Results from a clinical trial of more than 250 participants with progressive multiple sclerosis revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side effects of ibudilast were gastrointestinal and headaches. The study was supported by the National Institute of Neurological Disorders and… Read more »

People with primary progressive MS need ocrelizumab now

Source MS Society: Ocrelizumab should be available on the NHS for everyone with primary progressive MS who could benefit. We call on NHS England, the National Institute of Health and Care Excellence (NICE) and Roche to work together to secure a deal to make that happen. Raise your voice and help the MS Society tell NICE and… Read more »

MS Annual Quiz Night, Friday 12th October

MS Annual Quiz Night, Friday 12th October, The Barn (Didcot Conservative Club), 7 for 7.30 start, £7 per person, up to 8 in a team.  Please advertise to your friends, put on your facebook post etc. Please please can members donate some raffle prizes, especially drink, chocolates, biscuits etc. Many thanks,   Click here for… Read more »

Novel sub type of Multiple Sclerosis

Source Science Daily: Cleveland Clinic researchers have discovered a new subtype of multiple sclerosis (MS), providing a better understanding of the individualized nature of the disease. MS has long been characterized as a disease of the brain’s white matter, where immune cells destroy myelin — the fatty protective covering on nerve cells. The destruction of myelin… Read more »

Other brain diseases reveal clues to primary progressive MS

Source MS Research Australia: Brain disease genes linked to primary progressive MS risk.  Despite many genes being found that contribute to the risk of developing MS, so far research has not identified genes that are specific for the risk of developing the primary progressive form of MS. Now, a new international study has shown that rare… Read more »

What is SymTrac™

Source Novartis: SymTrac™ is a free app available on iPhone and Android that helps people with Multiple Sclerosis (MS) track general wellbeing and symptoms over time. The data recorded can be viewed in easy-to-read charts and shared with MS specialist teams to enhance consultation time and support decision making. SymTrac™ is the first MS app to… Read more »